香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 SITC International Holdings Company Limited 1308 董事會召開日期 海豐國際控股有限公司（「本公司」）董事會（「董事會」）茲通告謹定於二零二五年 八月十五日（星期五）舉行董事會會議，以考慮及通過本公司及其附屬公司截至 二零二五年六月三十日止的六個月中期業績，及派發中期股息（如有），以及處 理其他事項。 承董事會命 海豐國際控股有限公司 主席 楊現祥 中華人民共和國，二零二五年八月五日 於本公告日期，本公司之執行董事為楊現祥先生、薛明元先生、劉克誠先生及賴智勇先生；非執行 董事為楊馨女士；獨立非執行董事為謝少毅先生、廖家瑩博士及胡曼恬博士。 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's performance slightly exceeded expectations, with a projected net profit of approximately $180-200 million for the first half of 2025, representing a year-on-year increase of 220%-225% compared to $56 million in the same period of 2024 [9] - The increase in performance is attributed to the rise in freight rates due to market conditions and the contribution of new capacity delivered in 2024 [9] - The report highlights strong freight performance in Southeast Asia, with significant year-on-year growth in freight rates and volumes [9] Financial Data and Profit Forecast - Revenue projections (in million USD): - 2023: 875 - 2024: 1,340 - 2025E: 1,351 - 2026E: 1,299 - 2027E: 1,539 - Year-on-year growth rates: - 2023: -64% - 2024: 53% - 2025E: 0.8% - 2026E: -4% - 2027E: 19% [8] - Net profit projections (in million USD): - 2023: 21 - 2024: 366 - 2025E: 378 - 2026E: 334 - 2027E: 449 - Year-on-year growth rates for net profit: - 2023: -98% - 2024: 1,667% - 2025E: 3% - 2026E: -12% - 2027E: 34% [8] - The company maintains a low PE ratio of 4.8, significantly below comparable companies, supporting the "Buy" rating [9][10]

公司名稱: 海豐國際控股有限公司 呈交日期: 2025年8月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01308 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | HKD | | 0.1 HKD | | 500,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 5,000,000,000 | HKD | | 0.1 HKD | | 500,000,000 | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 本月底法定/註冊股本總額： HKD 500,000,000 致：香港交易及結算 ...

Core Insights - The China Securities Hong Kong 300 Transportation Index (H300 Transportation) has shown significant growth, with a 14.29% increase over the past month, 26.48% over the past three months, and 21.50% year-to-date [1]. Group 1: Index Overview - The H300 Transportation Index is composed of selected securities from the China Securities Hong Kong 300 Index, focusing on industries such as banking, transportation, resources, infrastructure, logistics, and leisure [1]. - The index was established on December 31, 2004, with a base point of 1000.0 [1]. Group 2: Index Holdings - The top ten weighted stocks in the H300 Transportation Index include ZTO Express (22.28%), J&T Express (21.3%), COSCO Shipping Holdings (12.02%), and others, with a total of 100% of holdings in the Hong Kong Stock Exchange [1]. - The sector breakdown of the index holdings shows that express delivery accounts for 43.58%, shipping for 32.32%, air transportation for 10.74%, logistics for 7.75%, highways for 3.23%, and ports for 2.38% [2]. Group 3: Index Adjustment Mechanism - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2]. - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2].

Core Insights - The China Securities Hong Kong 200 Momentum Index has shown significant growth, with a 9.06% increase over the past month, 26.45% over the past three months, and 36.25% year-to-date [1] Group 1: Index Performance - The index closed at 3887.18 points, reflecting a low opening followed by a strong recovery [1] - The index is based on a sample of securities listed on the Hong Kong Stock Exchange, utilizing various investment strategies [1] Group 2: Index Holdings - The top ten holdings of the index include: - Kangfang Biotech (5.99%) - Kingdee International (3.4%) - Sangfor Technologies (3.09%) - China Tower (2.72%) - New China Life Insurance (2.67%) - CITIC Securities (2.63%) - People's Insurance Company of China (2.42%) - Meitu (2.25%) - Hainan Airlines (2.22%) - Guotai Junan Securities (2.17%) [1] - The index is fully composed of stocks listed on the Hong Kong Stock Exchange [1] Group 3: Sector Allocation - The sector distribution of the index holdings is as follows: - Healthcare: 21.32% - Financials: 19.31% - Information Technology: 13.36% - Communication Services: 9.95% - Consumer Discretionary: 8.75% - Industrials: 8.61% - Materials: 6.38% - Consumer Staples: 5.30% - Utilities: 3.62% - Real Estate: 3.41% [2] Group 4: Index Adjustment - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2]

Core Viewpoints - The employment data has severely impacted market confidence, leading to declines in major indices such as the Hang Seng Index, which fell by 1.07% [2] - The market is experiencing a significant sell-off, with a notable increase in short-selling activity, indicating a bearish sentiment among investors [2][4] Company Overview - The specific company under review, Zhonghui Biotech, was established in 2015 and focuses on the development of innovative vaccines, including a quadrivalent influenza vaccine and a freeze-dried rabies vaccine [10] - The quadrivalent influenza vaccine was launched in May 2023, marking it as the first and only approved vaccine of its kind in China [10] - The company is currently in a loss-making position, with projected revenues of 52.2 million and 259.6 million for 2023 and 2024 respectively, while total losses are expected to reach 424.7 million and 258.7 million for the same years [10] Industry Status and Outlook - The Chinese human vaccine market is projected to grow significantly, from 53.5 billion in 2019 to 96.1 billion by 2024, with a CAGR of 12.4% [11] - By 2033, the market is expected to reach 331.9 billion, driven by technological advancements, increased public awareness of vaccination, and supportive preventive healthcare policies [11] Advantages and Opportunities - The company has the potential to address unmet needs in the high-quality vaccine market with its quadrivalent influenza vaccine, which offers higher safety and better immune response [12] - A leading R&D technology platform supports the development of its vaccine pipeline, which includes 11 additional vaccines currently in research [12] Fundraising and Use of Proceeds - The IPO is set to raise funds with approximately 63.6% allocated for the development and registration of core products, while 18.1% will be used for other vaccine developments [16] - The remaining funds will enhance production capabilities and support operational costs [16] Investment Recommendation - The IPO price range is set between 12.9 and 15.5 HKD, with a post-IPO market capitalization estimated at 50.75 to 60.98 billion HKD [17] - The valuation appears high when compared to peers, with a projected PS ratio of 17.9 to 21.6 for 2024 [17]

Core Viewpoint - The company has entered into a shipbuilding contract for the construction of four container vessels, indicating a strategic expansion in its fleet capacity [1] Group 1: Contract Details - The contract was signed on August 2, 2025, between the company's wholly-owned subsidiary and the shipbuilder [1] - Each vessel will cost up to $38,180,000, equivalent to approximately HKD 299,713,000 [1] - The total cost for all four vessels could reach up to $152,720,000, which is about HKD 1,198,852,000 [1]

马士基是全球最大集装箱航运公司之一。该条航线是马士基首条中国厦门到菲律宾马尼拉直航航线，挂 靠路径为"仁川-新港-宁波-厦门-马尼拉南港-上海"，全程覆盖东亚与东南亚核心港口。航线开通后，厦 门至马尼拉运输时间仅需3天。 【东盟专线】厦门港至马尼拉南港开通新航线 "马尼拉南港是菲律宾重要枢纽，但此前厦门直航航线较少，PH1航线的开通为中菲经贸往来提供更便 捷通道。"厦门边检总站东渡边检站执勤二队副队长王俊斌说。 中新社厦门8月3日电 (林永传卢颖臻) 8月3日，马士基近洋菲律宾线PH1航线正式开通。 该站针对PH1航线等以运输高时效跨境电商货物为主的船舶开通"绿色通道"，对高时效货类实施优先验 放，同时优化船员换班流程，实现换班环节无缝衔接，极大提高作业效率和码头周转率。 近年来，厦门港持续强化与东盟国家航运联通，先后引入马士基HP2航线(厦门-越南海防)、海丰集运 CPX7航线(厦门-菲律宾伊洛伊洛)等优质航线。(完) （文章来源：中国新闻网） ...

Major Events - InnoCare (02577) collaborates with NVIDIA to promote the large-scale implementation of 800 VDC (800-volt direct current) power architecture in AI data centers [1] - Zijin Mining (02899) receives parliamentary approval for the mining lease of Akyem gold mine in Ghana [1] - Codi-B (02487) receives approval from the Hong Kong Department of Health for the market launch of CU-40102 (topical finasteride spray) [1] - China Ruyi (00136) plans to issue a total of 1.3 billion subscription shares at a discount of approximately 4.46%, raising about HKD 38.95 billion [1] - Sinopec Engineering (02386) signs a front-end engineering design (FEED) contract for a large green hydrogen project in Yanbu, Saudi Arabia [1] - China Resources Land (01109) and a joint venture with Shanghai Nanfang acquire the Shanghai Yaohua Road project and Yuqingli project for approximately HKD 24.47 billion [1] - Global Industrial Technology (01026) intends to acquire a shopping mall property in Guangzhou's Yuexiu District for no more than HKD 260 million [1] - Corning Jereh Pharmaceutical-B (09966) has its IND application for JSKN022 officially accepted by CDE [1] - Sea Harvest International (01308) signs a shipbuilding contract with Huanghai Shipbuilding for the construction of four container ships [1] - Yika (09923) successfully completes registration as a "credit card number and contract conclusion business operator" in Japan [1] Operating Performance - Far East Horizon (03360) reports a mid-term profit attributable to shareholders of HKD 2.164 billion, an increase of 3.77% year-on-year [1] - Xinyi Energy (03868) reports a mid-term profit attributable to equity holders of HKD 450 million, an increase of 23.43% year-on-year [1] - Xinyi Solar (00968) reports a mid-term profit attributable to shareholders of HKD 746 million, a decrease of 58.8% year-on-year [1] - Xinyi Glass (00868) reports a mid-term profit attributable to shareholders of HKD 1.013 billion, a decrease of 59.64% year-on-year [1] - Xiehe New Energy (00182) continues to reduce financing costs and improve financing capabilities, with significant growth in green electricity business in the first half of the year [1] - PCCW (00008) reports a mid-term loss attributable to shareholders of HKD 445 million, a year-on-year narrowing of 3.68% [1] - Huishang Bank (03698) issues a profit warning, expecting mid-term net profit of approximately HKD 9.3 billion, a year-on-year increase of about 3.8% [1] - BYD (01211) reports sales of approximately 2.4903 million new energy vehicles in the first seven months, a year-on-year increase of 27.35% [1] - NIO-SW (09866) reports cumulative vehicle deliveries of 806,700 units as of the end of July [1] - XPeng Motors-W (09868) delivers 36,717 smart electric vehicles in July, a year-on-year increase of 229% [1] - Li Auto-W (02015) delivers 30,731 new vehicles in July [1] - Geely Automobile (00175) reports total vehicle sales of 237,700 units in July, a year-on-year increase of approximately 58% [1] - Great Wall Motors (02333) reports total vehicle sales of approximately 674,200 units in the first seven months, a year-on-year increase of 3.57% [1]

Core Viewpoint - The company, Haifeng International (01308), has announced a shipbuilding contract with Huanghai Shipbuilding for the construction of four container vessels, indicating an expansion of its fleet to meet operational demands [1] Group 1: Contract Details - The contract was signed on August 2, 2025, between Haifeng Shipping, a wholly-owned subsidiary of the company, and Huanghai Shipbuilding [1] - Each vessel will cost up to $38.18 million, equivalent to approximately HKD 299.7 million [1] - The total cost for the four vessels will be up to $152.7 million, equivalent to approximately HKD 1.199 billion [1] Group 2: Strategic Implications - The new vessels will enable the company to expand its owned container fleet [1] - This expansion is aimed at meeting the growing operational demands of the company [1]